Morgan Stanley

13F Holdings History for Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH)

Symbol: EVH on NYSE
Investment type: Equity / Class A Common Stock, par value $0.01 per share
Latest Disclosed Ownership: 8.21M shares
Security Ownership: 7%

Shares, Excluding Options vs Price

Value, Excluding Options

Morgan Stanley ownership in Evolent Health, Inc. Class A Common Stock, par value $0.01 per share (EVH)

2025-08-06 - Morgan Stanley has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 8.21M shares of Evolent Health, Inc. Class A Common Stock, par value $0.01 per share (EVH). This represents 7% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Morgan Stanley	7%		$76.1M	8.21M			$9.27	13G	6/30/2025	6 Aug 2025 16:32:15

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0.01%	+0%	$90.7M	8.05M	+3,271,899	+68.4%	$11.26	Q2 2025
3/31/2025	0%	+0%	$45.3M	4.78M	+4,210,321	+700%	$9.47	Q1 2025
12/31/2024			$17.00	1			$17.00^*	Q4 2024
12/31/2024	0%	0%	$6.42M	570K	-132,178		$11.25	Q4 2024
9/30/2024	0%	0%	$19.9M	703K	-89,064		$28.28	Q3 2024
6/30/2024	0%	+0%	$15.1M	792K	+203,009		$19.12	Q2 2024
3/31/2024	0%		$56.00	1			$56.00^*	Q1 2024
3/31/2024	0%		$19.3M	589K			$32.79	Q1 2024
12/31/2023	0%		$19.1M	578K			$33.03	Q4 2023
12/31/2023	0%		$58.00	1			$58.00^*	Q4 2023
9/30/2023	0%	+0%	$16.9M	619K	+124,950	+25.3%	$27.23	Q3 2023
6/30/2023	0%	+0%	$15M	494K	+60,474	+13.9%	$30.30	Q2 2023
3/31/2023	0%	+0%	$14.1M	434K	+61,690	+16.6%	$32.45	Q1 2023
12/31/2022	0%	0%	$10.4M	372K	-237,208	-38.9%	$28.08	Q4 2022
9/30/2022	0%	+0%	$21.9M	609K	+349,164	+134%	$35.93^*	Q3 2022
6/30/2022	0%	+0%	$7.99M	260K	+58,377	+28.9%	$30.71	Q2 2022
3/31/2022	0%	0%	$6.52M	202K	-6,148	-2.96%	$32.30	Q1 2022
12/31/2021	0%	0%	$5.75M	208K	-305,859	-59.5%	$27.66	Q4 2021
9/30/2021	0%	+0%	$15.9M	514K	+63,924	+14.2%	$31.00	Q3 2021
6/30/2021	0%	+0%	$9.5M	450K	+268,219	+148%	$21.12	Q2 2021
3/31/2021	0%	0%	$3.67M	182K	-114,804	-38.7%	$20.20	Q1 2021
12/31/2020	0%	+0%	$4.75M	296K	+138,998	+88.3%	$16.03	Q4 2020
9/30/2020	0%	0%	$1.95M	157K	-9,436	-5.66%	$12.41	Q3 2020
6/30/2020	0%	+0%	$1.19M	167K	+1,742	+1.06%	$7.12^*	Q2 2020
3/31/2020	0%	0%	$897K	165K	-105,871	-39.1%	$5.43^*	Q1 2020
12/31/2019	0%	+0%	$2.45M	271K	+131,497	+94.3%	$9.05	Q4 2019
9/30/2019	0%	0%	$1M	139K	-554,335	-79.9%	$7.19^*	Q3 2019
6/30/2019	0%	+0%	$5.52M	694K	+270,113	+63.8%	$7.95^*	Q2 2019
3/31/2019	0%	+0%	$5.33M	424K	+130,487	+44.5%	$12.58	Q1 2019
12/31/2018	0%	+0%	$5.85M	293K	+122,397	+71.7%	$19.95	Q4 2018
9/30/2018	0%	0%	$4.85M	171K	-37,891	-18.2%	$28.41	Q3 2018
6/30/2018	0%	+0%	$4.39M	209K	+27,799	+15.4%	$21.05	Q2 2018
3/31/2018	0%	+0%	$2.58M	181K	+26,437	+17.1%	$14.25^*	Q1 2018
12/31/2017	0%	+0%	$1.9M	154K	+30,842	+25%	$12.30	Q4 2017
9/30/2017	0%	+0%	$2.2M	124K	+18,647	+17.8%	$17.79^*	Q3 2017
6/30/2017	0%	0%	$2.66M	105K	-2,616	-2.43%	$25.35	Q2 2017
3/31/2017	0%	0%	$2.4M	108K	-50,269	-31.9%	$22.30	Q1 2017
12/31/2016	0%	+0%	$2.34M	158K	+136,900	+654%	$14.80	Q4 2016
9/30/2016	0%	+0%	$515K	20.9K	+5,453	+35.2%	$24.61	Q3 2016
6/30/2016	0%	0%	$297K	15.5K	-740	-4.56%	$19.19	Q2 2016
3/31/2016	0%	0%	$171K	16.2K	-3,838	-19.1%	$10.55	Q1 2016
12/31/2015	0%	0%	$243K	20.1K	-183	-0.9%	$12.12	Q4 2015
9/30/2015	0%	0%	$323K	20.2K	-43,147	-68.1%	$15.96	Q3 2015
6/30/2015	0%	+0%	$1.24M	63.4K	+63,381	NEW	$19.50	Q2 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.